Prostate Cancer Spurs New Nerves Science Daily (press release) - "We also believe that axongenesis and neurogenesis is found not only in prostate cancer, but is potentially a more global phenomenon, particularly relating ...
Health Buzz: World AIDS Day and Other Health News U.S. News & World Report, DC - 44 minutes ago Last year, US News explained how robotic surgery and other newer technologies are tackling early-stage prostate cancer. This September, Nancy Shute ...
Raised hopes for prostate cancer sufferers Times Online, UK - Not everyone's general health makes them suitable for radical treatment and some patients may have tumours too advanced for the cancer to be eradicated. ...
Radiotherapy Safe for Prostate Cancer in HIV-Infected Patients Cancerpage.com, GA - 52 minutes ago NEW YORK DEC 01, 2008 (Reuters Health) - The results of small study suggest that radiotherapy can be safely used to treat prostate cancer in HIV-infected ...
108 holes not a bad round! Sunshine Coast Daily, Australia - In doing so, he raised more than $6000 for prostate cancer research. Shortly after closing out his sixth round of the day, Matt said he felt he had more ...
Date set for cancer services transfer RTE.ie, Ireland - ... Professor Tom Keane said that after the breast cancer organisation, he would focus on prostate and lung cancer service reform. He said he was not fond ...
Source: Google News
Recent News and Articles on the Keywords: cancer + prostate + treatment Related to the article below (Last Update: 8/5/2008)
Gold seeds to fight prostate cancer Portsmouth Herald News, NH - ?The (seeds) improve the imaging in treatment for prostate cancer. You?re able to locate the prostate before treatment and therefore adjust treatment so ...
MDs urged to quit prostate screens in elderly men The Associated Press - The testing and treatment of this cancer have been a long-running debate. Earlier this year, a study found that older men who already had early-stage ...
Study links prostate cancer, Agent Orange NavyTimes.com, VA - By Kelly Kennedy - Staff writer Vietnam veterans exposed to Agent Orange are nearly twice as likely to have prostate cancer ? especially in its most ...
Surgical side effects cut with robotics CNN - In this case, the surgeon is removing a man's prostate gland. Robotic surgery is a growing trend in treating prostate cancer. ...
Jimmy V Event to Highlight Prostate Cancer Southern Pines Pilot, NC - About 16 percent of American men will be diagnosed with prostate cancer sometime in their lives. Treatment options and prognosis depend on several factors, ...
GTx, Inc. Reports Second Quarter 2008 Financial Results StreetInsider.com (subscription), MI - ... and treatment of other key estrogen related serious side effects of ADT in men with advanced prostate cancer," said Mitchell S. Steiner, MD, CEO of GTx. ...GTXI
Quality-of-life outcomes in men treated for localized prostate cancer - MS Litwin, RD Hays, A Fink, PA Ganz, B Leake, GE … - JAMA, 1995 - Am Med Assoc ... General Quality of Life 2 Years Following Treatment for ProstateCancer: What
Influences Outcomes? ... Quality of Life After ProstateCancerTreatment Lee et al. ...
Men with prostate cancer who have not responded to conventional treatments may benefit from supplements containing a modified form of a fruit ingredient, preliminary research suggests.
After 13 men with prostate cancer that did not respond to conventional treatment tried supplements containing modified fruit pectin (MCP) for 12 months, 7 of the 10 men who completed the study showed signs that their tumors were becoming less aggressive.
The study was sponsored by EcoNugenics, the company that sells the MCP supplements used in the current research.
All of the men underwent previous treatment for their tumors, including surgery and radiation, after which they had all experienced an increase in prostate specific antigen (PSA) in their blood, a sign their cancer was continuing to grow.
Three of the patients did not complete the full course of treatment with MCP due to mild abdominal cramps or diarrhea, which resolved after they stopped the treatment.
In an interview, study author Brad Guess said that the results are too preliminary to warrant recommending MCP to all men with prostate cancer. However, the findings show that, for men with recurrent cancer who can handle the side effects, MCP may help, he noted.
"It may have some benefit as a relatively non-toxic agent in a select group of guys with a rising PSA," Guess, a physician’s assistant at Prostate Oncology Specialist in California.
He added that pectin naturally occurs in the peel of citrus fruit, and is generally not absorbed by the bloodstream. So eating large quantities of fruit likely won’t bring about the same benefit as taking a supplement, which contains pectin that is modified so that it is absorbed in the bloodstream, he said.
During the study, reported in the journal Prostate Cancer and Prostatic Diseases, Guess and his team asked 13 men with prostate cancer to take six capsules of MCP three times per day for one year, for a total daily dose of 14.4 grams.
Among the 10 patients who completed the study, seven experienced a slower rise in blood levels of PSA, a sign that their tumors were becoming less aggressive.
In an interview, study co-author Dr. Stephen Strum, an oncologist specializing in prostate cancer in Oregon, explained that previous experiments have shown that MCP may block an important substance that enables cancer to grow and spread.
According to Strum, our immune system is typically strong enough to fight off individual cancer cells. To outwit our natural defenses, he said, cancer cells exhibit a protein on their surfaces that enables them to combine together, forming a clump large enough to become a threat to health.
"The cohesiveness of the enemy cells, the tumor cells, is an important factor for the cancer to grow and spread," Strum explained.
Recently, investigators discovered that MCP blocks this surface protein, known as galectin-3, which may explain why it helps men with prostate cancer, Strum noted.
Guess added that MCP may also work in people with other types of cancer, as well.